We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CEPI Extends Collaboration With Novavax To Advance Development and Manufacture of COVID-19 Vaccine

Product News   May 14, 2020

 
CEPI Extends Collaboration With Novavax To Advance Development and Manufacture of COVID-19 Vaccine
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Collaboration to Produce AT-100 as Promising New Candidate for Coronavirus

Product News

Airway Therapeutics, Inc. and Celonic Group have announced a collaboration to produce the novel human recombinant protein AT-100 (rhSP-D) as a therapeutic candidate against COVID-19.

READ MORE

New Neuroinflammation Discovery Services Offer Advanced Insight into Chronic Pain

Product News

Cellectricon has announced the launch of services offering for exploration of the role of neuroinflammation in chronic pain.

READ MORE

300 Antibodies Generated That Have Neutralization Potential Against SARS-CoV-2

Product News

Prellis Biologics, Inc. announced that it has generated 300 human IgG antibodies that bind to either the S1 or S2 spike protein of the SARS-CoV2-Wuhan strain of the novel coronavirus.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE